PUCOTENLIMAB
UNII CGA81G3KR5

Substance Identification & Data

This profile provides standardized clinical and technical data for Pucotenlimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CGA81G3KR5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2403647-03-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

CGA81G3KR5

CAS Registry Number

2403647-03-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PUCOTENLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C160717

National Cancer Institute reference terminology for clinical and research data.

INN ID

11561

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pucotenlimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PUCOTENLIMAB

Common Names & Synonyms

HUMANIZED PD-1 BLOCKING ANTIBODY HX-008

IMMUNOGLOBULIN G4 (252-THERONINE,306-PROLINE,432-ALANINE), ANTI-(HUMAN PROGRAMMED CELL DEATH 1) (HUMAN-MUS MUSCULUS MONOCLONAL HX008 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HX008 .KAPPA.-CHAIN, DIMER

PUCOTENLIMAB [INN]

PUCOTENLIMAB [WHO-DD]